Etid klinik pou BPCO nan North Carolina
22 etid pou BPCO ap chèche patisipan nan sit nan North Carolina.
Vil nan North Carolina
Tèks ofisyèl etid la (Anglè)
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- East Carolina University- Site Number : 8400102, Greenville
- Piedmont Healthcare - Family Medicine- Site Number : 8400022, Statesville
- All-Trials Clinical Research- Site Number : 8400008, Winston-Salem
Ap rekriteFaz 3
Laj 40 a 80 · Tout sèks · Mizajou Oct 1, 2026 · NCT07190222To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
- Carolina Research Center, Inc., Shelby
Ap rekriteFaz 2
Laj 40 a 85 · Tout sèks · Mizajou Sep 30, 2026 · NCT07684820A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
- American Health Research - Charlotte- Site Number : 8400013, Charlotte
- Atrium Health Wake Forest Baptist Pulmonary, Sleep And Allergy- Site Number : 8400004, Winston-Salem
Ap rekriteFaz 4
Laj 40 a 85 · Tout sèks · Mizajou Sep 22, 2026 · NCT07053423Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- Duke Asthma, Allergy and Airway Center- Site Number : 8400047, Durham
- Advanced Respiratory and Sleep Medicine - Hickory- Site Number : 8400013, Hickory
- Science 37, Llc- Site Number : 8400154, Morrisville
- ak 1 plis
Ap rekriteFaz 3
Laj 40 a 80 · Tout sèks · Mizajou Sep 22, 2026 · NCT07190209A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)
- WB Contracted Clinical Research Site, Charlotte
Ap rekriteFaz 2
Laj 40 a 80 · Tout sèks · Mizajou Sep 15, 2026 · NCT07646587Nebulizer Versus Handheld Maintenance Therapy for Patients With COPD
- Southeastern Research Center, Winston-Salem
Ap rekriteFaz 4
Laj 60 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT07816835A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, New Bern
Ap rekriteFaz 2
Laj 40 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT07082738A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Charlotte
- Research Site, Concord
Ap rekriteFaz 3
Laj 40 a 80 · Tout sèks · Mizajou Sep 3, 2026 · NCT06878261A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, High Point
- Research Site, Kings Mountain
- Research Site, New Bern
- ak 1 plis
Ap rekriteFaz 3
Laj 40 a 80 · Tout sèks · Mizajou Sep 3, 2026 · NCT06883305A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease
- University of North Carolina Clinical Research Center, Chapel Hill
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT06603246The Study of Chronic Obstructive Pulmonary Disease (COPD) Participants Treated With Dupilumab (STRIDE) Registry
- Duke, Durham
Ap rekriteEtid obsèvasyon
Laj 40 ak plis · Tout sèks · Mizajou Sep 1, 2026 · NCT07612878A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- Salem Chest Specialists, Winston-Salem
- Southeastern Research Center, Winston-Salem
Ap rekriteFaz 2/3
Laj 35 a 80 · Tout sèks · Mizajou Aug 31, 2026 · NCT07363694Inhaled Treprostinil (Tyvaso Nebulizer) For COPD Patients With Hypoxemia
- Duke Asthma Allergy and Airway Center, Durham
Ap rekriteFaz 2
Laj 40 ak plis · Tout sèks · Mizajou Aug 27, 2026 · NCT07037836Photon-counting CT in Chest Imaging
- Duke University Hospital, Durham
Ap rekrite
Tout laj · Tout sèks · Mizajou Aug 26, 2026 · NCT07031336A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Greensboro
- Research Site, Greenville
- Research Site, Huntersville
- ak 3 plis
Ap rekriteFaz 3
Laj 40 a 80 · Tout sèks · Mizajou Aug 26, 2026 · NCT06283966STRIVE Post-Market Registry Study
- Duke University Medical Center, Durham
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Aug 3, 2026 · NCT04302272eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
- GSK Investigational Site, Winston-Salem
Ap rekriteFaz 3
Laj 40 a 75 · Tout sèks · Mizajou Jul 28, 2026 · NCT07177339SPIROMICS Study of Early COPD Progression (SOURCE)
- Wake Forest, Winston-Salem
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 30 a 55 · Tout sèks · Mizajou Jun 3, 2026 · NCT05033990Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
- Wake Forest School of Medicine, Salem
Ap rekrite
Laj 40 a 80 · Tout sèks · Mizajou Apr 28, 2026 · NCT07051707Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
- GSK Investigational Site, Shelby
Ap rekriteFaz 3
Laj 40 a 80 · Tout sèks · Mizajou Apr 9, 2026 · NCT06961214Pulmonary Hypertension SOLAR
- Duke University Medical Center, Durham
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Feb 24, 2026 · NCT04778046Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- Wakemed, Raleigh
Ap rekriteEtid obsèvasyon
Laj 50 ak plis · Tout sèks · Mizajou Aug 5, 2025 · NCT06122077Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.